ADM announced the appointment of Dr. Nuria Miquel as senior vice president and chief science officer, effective August 1. Miquel started her career as a research scientist before progressing to leadership roles at Novozymes, Tate & Lyle, Chr. Hansen and Hempel. She joined ADM three years ago as leader of science and technology for the company's Nutrition segment.

Miquel earned her Ph.D from the University of Copenhagen and University of Bristol, on the effect of nutrition to immune responses in monogastric parasitic infections. Miquel will replace Dr. Todd Werpy, who has announced his retirement after leading ADM's R&D and innovation efforts for 16 years.